OBJECTIVE: To investigate trends in adult mortality in a population serviced by a public-sector antiretroviral therapy (ART) programme in rural South Africa using a demographic surveillance system. METHODS: Verbal autopsies were conducted for all 7930 deaths observed between January 2000 and December 2006 in a demographic surveillance population of 74,500 in the Umkhanyakude district of northern KwaZulu-Natal province, South Africa. Age-standardized mortality rate ratios (SMRRs) were calculated for adults aged 25 to 49 years, the group most affected by HIV, for the 2 years before 2004 and the 3 subsequent years, during which ART had been available. FINDINGS: Between 2002-2003 (the period before ART) and 2004-2006 (the period after ART), HIV-related age-standardized mortality declined significantly, from 22.52 to 17.58 per 1000 person-years in women 25-49 years of age (P < 0.001; SMRR: 0.780; 95% confidence interval, CI: 0.691-0.881), and from 26.46 to 18.68 per 1000 person-years in men 25-49 years of age (P < 0.001; SMRR: 0.706; 95% CI: 0.615-0.811). On sensitivity analysis the results were robust to the possible effect of misclassification of HIV-related deaths. CONCLUSION: Overall population mortality and HIV-related adult mortality declined significantly following ART roll-out in a community with a high prevalence of HIV infection. A clear public health message of the benefits of treatment, as revealed by these findings, should be part of a multi-faceted strategy to encourage people to find out their HIV serostatus and seek care.
OBJECTIVE: To investigate trends in adult mortality in a population serviced by a public-sector antiretroviral therapy (ART) programme in rural South Africa using a demographic surveillance system. METHODS: Verbal autopsies were conducted for all 7930 deaths observed between January 2000 and December 2006 in a demographic surveillance population of 74,500 in the Umkhanyakude district of northern KwaZulu-Natal province, South Africa. Age-standardized mortality rate ratios (SMRRs) were calculated for adults aged 25 to 49 years, the group most affected by HIV, for the 2 years before 2004 and the 3 subsequent years, during which ART had been available. FINDINGS: Between 2002-2003 (the period before ART) and 2004-2006 (the period after ART), HIV-related age-standardized mortality declined significantly, from 22.52 to 17.58 per 1000 person-years in women 25-49 years of age (P < 0.001; SMRR: 0.780; 95% confidence interval, CI: 0.691-0.881), and from 26.46 to 18.68 per 1000 person-years in men 25-49 years of age (P < 0.001; SMRR: 0.706; 95% CI: 0.615-0.811). On sensitivity analysis the results were robust to the possible effect of misclassification of HIV-related deaths. CONCLUSION: Overall population mortality and HIV-related adult mortality declined significantly following ART roll-out in a community with a high prevalence of HIV infection. A clear public health message of the benefits of treatment, as revealed by these findings, should be part of a multi-faceted strategy to encourage people to find out their HIV serostatus and seek care.
Authors: Eduard J Beck; Marco Vitoria; Sundhiya Mandalia; Siobhan Crowley; Charles F Gilks; Yves Souteyrand Journal: AIDS Date: 2006-07-13 Impact factor: 4.177
Authors: Martin Adjuik; Tom Smith; Sam Clark; Jim Todd; Anu Garrib; Yohannes Kinfu; Kathy Kahn; Mitiki Mola; Ali Ashraf; Honorati Masanja; Kubaje Adazu; Ubaje Adazu; Jahit Sacarlal; Nurul Alam; Adama Marra; Adjima Gbangou; Eleuther Mwageni; Fred Binka Journal: Bull World Health Organ Date: 2006-03-22 Impact factor: 9.408
Authors: E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo Journal: Ann Intern Med Date: 2001-07-03 Impact factor: 25.391
Authors: Antonella d'Arminio Monforte; Donald Abrams; Christian Pradier; Rainer Weber; Peter Reiss; Fabrice Bonnet; Ole Kirk; Matthew Law; Stephane De Wit; Nina Friis-Møller; Andrew N Phillips; Caroline A Sabin; Jens D Lundgren Journal: AIDS Date: 2008-10-18 Impact factor: 4.632
Authors: Jacob Bor; Till Bärnighausen; Colin Newell; Frank Tanser; Marie-Louise Newell Journal: Trop Med Int Health Date: 2011-05-26 Impact factor: 2.622
Authors: Josephine V J Lightowler; Graham S Cooke; Portia Mutevedzi; Richard J Lessells; Marie-Louise Newell; Martin Dedicoat Journal: PLoS One Date: 2010-01-07 Impact factor: 3.240
Authors: James Ndirangu; Till Bärnighausen; Frank Tanser; Khin Tint; Marie-Louise Newell Journal: Trop Med Int Health Date: 2009-09-07 Impact factor: 2.622